Home » Journals & Newsletters » CAPN CME Post-Test, Volume 16, Issue 6


Please Note: We can award CME credit only to subscribers.
Not a subscriber? See the CAPN page to subscribe.

To earn CME credit, you must read the designated article (page 1) in this issue of CAPN 16(6), 2011 and complete the quiz below, answering at least four of the questions correctly. If you would prefer to print and fax this test, please fax it to Medical Education Resources, Inc.; 1500 W. Canal Ct. Bldg. B, Littleton, CO 80120-6404; Fax: (720) 449-0217.

Only the first entry will be considered for credit and must be received by MER by January 31, 2013. Acknowledgment will be sent to you within six weeks of participation.

Medical Education Resources designates this educational activity for a maximum of 1 AMA PRA Category 1 credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 01/12 Expiration Date: 01/13

You will receive a copy of your completed test at the e-mail address you specify below.

CAPN 16(6): CME test for Clinical Pharmacology of Conduct Disorder: A Critical Review by Jelle R. Lettinga, M.D., Cora Drent, M.Sc., Pieter J. Hoekstra, M.D., Ph.D., Jan K. Buitelaar, M.D., Ph.D., and Jeffrey C. Glennon, Ph.D.

Please identify your answer by checking the appropriate letter that corresponds to your response.


1. Conduct disorder is a clinically heterogeneous disorder:

    A. which persists only as a subset of ADHD disorder.
    B. where repeated anti-social behavior is present and persistent.
    C. which is identified by learning disorders.
    D. which is short-term and episodic.

2. Pharmacotherapy is a first line treatment of Conduct Disorder.
    A. true
    B. false

3. There are four general categories of Conduct Disorder behavior: They are: (1) Covert Behaviors, (2) Rule Violation, __________.
    A. (3) Destruction of Property, and (4) Aggression toward Others
    B. (3) Hyperactivity, and (4) Cognitive Deficits
    C. (3) Callous Emotions, and (4) Loner Behavior
    D. none of the above

4. Which medication has the highest ranking of efficacy in general as well as efficacy against aggression?
    A. Lithium
    B. Methylphenidate
    C. Pemoline
    D. Quetiapine

5. The co-morbidity of ADHD confounds the understanding of methylphenidate in treating aggression in CD.
    A. true
    B. false


Name:
Degree:
Address Line 1:
(May be a company name)
Address Line 2:
(Optional)
City:
State or Province: US and Canada: Other:
Zip or Postal Code:
Country:
Phone Number:
Fax Number:
E-mail Address:
(Your e-mail address will not be released to any third party.)

Your evaluation of this CME activity (i.e., this issue) will help guide future planning. Please respond to the following questions on a scale of 1-5, with five being the highest:

1 2 3 4 5
1. Of how much practical value to you was the content?
2. Were the educational objectives met? yesno
EO1:
EO2:
1 2 3 4 5
3. As a result of meeting the educational objectives of this activity, how frequently will you incorporate the skills learned into your practice?
yesno
4. Was the activity free of bias for or against any commercial products?
5. How long did it take you to complete the CME activity?
6. To aid in future planning, please state one or two topics you would like to see addressed in future issues:

For customer service, please call (212) 431-9800, ext 249.

Note: A subscription enables you to participate in up to 6 hours of CME credit per year, at no additional cost. Tests must be received by Medical Education Resources CME by the due date listed in the issue, which is one year after publication. Acknowledgment will be sent to you by mail within six weeks of participation.

X
Save 15% + Free Shipping on Online Orders!

Guilford Press

Save 15%: Free Shipping:
For bulk orders, please contact: info@guilford.com
X
**enlarged_cover**